The Economic Burden of Dry Eye Disease in the United States: A Decision Tree Analysis

Purpose: The aim of this study was to estimate both the direct and indirect annual cost of managing dry eye disease (DED) in the United States from a societal and a payer's perspective. Methods: A decision analytic model was developed to estimate the annual cost for managing a cohort of patients with dry eye with differing severity of symptoms and treatment. The direct costs included ocular lubricants, cyclosporine, punctal plugs, physician visits, and nutritional supplements. The indirect costs were measured as the productivity loss because of absenteeism and presenteeism. The model was populated with data that were obtained from surveys that were completed by dry eye sufferers who were recruited from online databases. Sensitivity analyses were employed to evaluate the impact of changes in parameters on the estimation of costs. All costs were converted to 2008 US dollars. Results: Survey data were collected from 2171 respondents with DED. Our analysis indicated that the average annual cost of managing a patient with dry eye at $783 (variation, $757-$809) from the payers' perspective. When adjusted to the prevalence of DED nationwide, the overall burden of DED for the US healthcare system would be $3.84 billion. From a societal perspective, the average cost of managing DED was estimated to be $11,302 per patient and $55.4 billion to the US society overall. Conclusions: DED poses a substantial economic burden on the payer and on the society. These findings may provide valuable information for health plans or employers regarding budget estimation.

[1]  K. Rajagopalan,et al.  The Economic Burden of Dry Eye: A Conceptual Framework and Preliminary Assessment , 2004, Cornea.

[2]  E. Campos,et al.  A Novel Scraping Cytology Score System (SCSS) Grades Inflammation in Dry Eye Patients , 2009, Current eye research.

[3]  T. Edrington,et al.  The agreement between self-assessment and clinician assessment of dry eye severity. , 2005, Cornea.

[4]  A. Ludwig,et al.  Determinants of eye drop size. , 2004, Survey of ophthalmology.

[5]  Lee Stern,et al.  Dysfunctional Tear Syndrome: A Delphi Approach to Treatment Recommendations , 2006, Cornea.

[6]  J. Guest,et al.  The Annual Cost of Dry Eye Syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom Among Patients Managed by Ophthalmologists , 2006, Ophthalmic epidemiology.

[7]  Gerd Geerling,et al.  Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.

[8]  R. Dana,et al.  Impact of dry eye syndrome on vision-related quality of life. , 2007, American journal of ophthalmology.

[9]  J. Buring,et al.  Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. , 2009, Archives of ophthalmology.

[10]  T. Edrington,et al.  The Agreement Between Self-Assessment and Clinician Assessment of Dry Eye Severity , 2005 .

[11]  Gary C. Brown,et al.  Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome. , 2009, Archives of ophthalmology.

[12]  Ronald Klein,et al.  Incidence of dry eye in an older population. , 2003, Archives of ophthalmology.

[13]  Carolyn G. Begley,et al.  The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.

[14]  R. D. Stulting,et al.  Agreement of Physician Treatment Practices With the International Task Force Guidelines for Diagnosis and Treatment of Dry Eye Disease , 2007, Cornea.

[15]  A. Zbrozek,et al.  The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument , 1993, PharmacoEconomics.

[16]  C. Roberts,et al.  Comparison of Topical Cyclosporine, Punctal Occlusion, and a Combination for the Treatment of Dry Eye , 2007, Cornea.

[17]  M. Calonge.  The treatment of dry eye. , 2001, Survey of ophthalmology.

[18]  C. Dirksen,et al.  Societal Burden of Clinically Anxious Youth Referred for Treatment: A Cost-of-illness Study , 2008, Journal of abnormal child psychology.

[19]  Christophe Baudouin,et al.  The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.

[20]  J. Buring,et al.  Prevalence of dry eye syndrome among US women. , 2003, American journal of ophthalmology.

[21]  J. Walt,et al.  Utilization characteristics of topical cycolsporine and punctal plugs in a managed care database. , 2008, The American journal of managed care.